Status:
COMPLETED
Efficacy of RIPC to Reduce AKI for Patients Undergoing PCI
Lead Sponsor:
A.O.U. Città della Salute e della Scienza
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
The purpose of the present study is to determine if remote ischemic preconditioning reduces incidence of acute kidney injury in patients with reduced kidney function undergoing Percutaneous Coronary I...
Detailed Description
Acute kidney injury negatively impacts on prognosis after PCI, and only hydratation have shown to reduce this complication. Remote ischemic preconditioning has been demonstrated to reduce periprocedu...
Eligibility Criteria
Inclusion
- undergoing PCI with stenting for all clinical indications
- carrying (with) a renal clearance less than 60 mL/min/1.73 m2 and more than 30 mL/min/1.73 m2 (evaluated through MDRD); ù
- younger than 85 years old.
Exclusion
- ST Segment Elevation Myocardial Infarction (STEMI), unstable hemodynamic presentations (cardiogenic shock) or ongoing severe arrhythmias;
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
1110 Patients enrolled
Trial Details
Trial ID
NCT02195726
Start Date
January 1 2013
End Date
July 1 2014
Last Update
July 21 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Cardiovasculaire Paris Sud Hôpital Jacques Cartier
Paris, France
2
Unità Operativa di Cardiologia Presidio Ospedaliero Misericordia Via Senese 161 58100 Grosseto
Grosseto, Italy
3
Azienda Ospedaliere Senese Siena
Siena, Italy
4
Ospedale Maria Vittoria
Turin, Italy, 10016